Accountability of Investigation product [Study Per­for­mance]

posted by Ohlbe – France, 2018-02-05 11:38 (2325 d 06:11 ago) – Posting: # 18345
Views: 6,459

Dear anky1212,

I would expect the pharmacist to be informed of (or at least, to check the protocol for) any specific requirement or sponsor request, which would be different from the pharmacy's SOPs: are there specific storage conditions ? handling conditions ? how many IP units should be dispensed per subject ? etc.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,057 posts in 4,840 threads, 1,641 registered users;
127 visitors (0 registered, 127 guests [including 8 identified bots]).
Forum time: 18:50 CEST (Europe/Vienna)

You should treat as many patients as possible with the new drugs
while they still have the power to heal.    Armand Trousseau

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5